Infections caused by multidrug-resistant Pseudomonas aeruginosa are considered a major public health problem. Antibiotic options are scarce but new drugs are emerging and more maybe available in the near future. We will discuss this important topic with experts in the field.
This episode of Editors in Conversation is brought to you by the Antimicrobial Agents and Chemotherapy Journal and hosted by AAC Editor in Chief, Cesar Arias. AAC is available at https://asm.org/aac.
Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.
Subscribe to the podcast at https://asm.org/eic
👍 Subscribe to ASM's YouTube channel at https://goo.gl/mOVHlK
✅ Become a member today at https://asm.org/Membership
🔬 Learn more about the American Society for Microbiology at https://www.asm.org
📱 Join us on social:
Facebook: https://www.facebook.com/asmfan
Twitter: https://www.twitter.com/ASMicrobiology
Instagram: https://www.instagram.com/asmicrobiology/